1983Journal of Labelled Compounds and RadiopharmaceuticalsRequires access

Synthesis of 35S‐ and 14C‐labeled famotidine, a new potent histamine H2 receptor antagonist

Kazuharu Tamazawa, Hideki Arima

Open publisher page 4 citations

Abstract

Abstract Famotidine, 3‐[[[2‐[(diaminomethylene)amino]‐4‐thiazolyl]methyl]thio]‐ N2‐sulfamoylpropionamidine, a new potent histamine H2 receptor antagonist, was labeled with 35S and 14C for metabolic studies at specific activities of 45.7 μCi/mg (VIb) and 47.6 μCi/mg (VIc) respectively.

About this research paper

What this paper is about

Abstract Famotidine, 3‐[[[2‐[(diaminomethylene)amino]‐4‐thiazolyl]methyl]thio]‐ N2‐sulfamoylpropionamidine, a new potent histamine H2 receptor antagonist, was labeled with 35S and 14C for metabolic studies at specific activities of 45.7 μCi/mg (VIb) and 47.6 μCi/mg (VIc) respectively.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract Famotidine, 3‐[[[2‐[(diaminomethylene)amino]‐4‐thiazolyl]methyl]thio]‐ N2‐sulfamoylpropionamidine, a new potent histamine H2 receptor antagonist, was labeled with 35S and 14C for metabolic studies at specific activities of 45.7 μCi/mg (VIb) and 47.6 μCi/mg (VIc) respectively.

Key concepts: Famotidine, Chemistry, Histamine, Antagonist, Thio-, Histamine receptor, Histamine H2 receptor, Cimetidine

Related papers

Back to paper searchBrowse research topicsOriginal source
Synthesis of 35S‐ and 14C‐labeled famotidine, a new potent histamine H2 receptor antagonist — Research Paper | ScholarLens